Detalles de la búsqueda
1.
Phase 2 study of ibrutinib plus venetoclax in Japanese patients with relapsed/refractory mantle cell lymphoma.
Int J Clin Oncol
; 29(2): 232-240, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38157190
2.
Upadacitinib plus topical corticosteroids in atopic dermatitis: Week 52 AD Up study results.
J Allergy Clin Immunol
; 149(3): 977-987.e14, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34403658
3.
Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 397(10290): 2169-2181, 2021 06 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34023009
4.
Efficacy and safety results of depatuxizumab mafodotin (ABT-414) in patients with advanced solid tumors likely to overexpress epidermal growth factor receptor.
Cancer
; 124(10): 2174-2183, 2018 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29533458
5.
A phase 1 dose-escalation study of veliparib with bimonthly FOLFIRI in patients with advanced solid tumours.
Br J Cancer
; 118(7): 938-946, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29527010
6.
Network evolution and risk assessment of the global phosphorus trade.
Sci Total Environ
; 860: 160433, 2023 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36435253
7.
Long-Term Safety and Efficacy of Risankizumab in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: Results from a Phase 2 Open-Label Extension Trial.
Dermatol Ther (Heidelb)
; 11(2): 487-497, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33512666
8.
Pharmacokinetics of Upadacitinib With the Clinical Regimens of the Extended-Release Formulation Utilized in Rheumatoid Arthritis Phase 3 Trials.
Clin Pharmacol Drug Dev
; 8(2): 208-216, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29688617
9.
Use of Early Clinical Trial Data to Support Thorough QT Study Waiver for Upadacitinib and Utility of Food Effect to Demonstrate ECG Assay Sensitivity.
Clin Pharmacol Ther
; 103(5): 836-842, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28762476
10.
Pharmacokinetics of the B-Cell Lymphoma 2 (Bcl-2) Inhibitor Venetoclax in Female Subjects with Systemic Lupus Erythematosus.
Clin Pharmacokinet
; 57(9): 1185-1198, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29333561
Resultados
1 -
10
de 10
1
Próxima >
>>